218 related articles for article (PubMed ID: 29942152)
1. A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma.
Yu Y; Feng X; Cang S
Cancer Manag Res; 2018; 10():1507-1515. PubMed ID: 29942152
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Li A; Hou S; Chen J; Jiang Y
Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
[No Abstract] [Full Text] [Related]
6. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes.
Yang J; Wei X; Hu F; Dong W; Sun L
Cancer Cell Int; 2022 Jan; 22(1):21. PubMed ID: 35033072
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma.
Ma Y; Tang R; Huang P; Li D; Liao M; Gao S
Front Pharmacol; 2024; 15():1332042. PubMed ID: 38572434
[No Abstract] [Full Text] [Related]
8. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu S; Liu Z; Wu X; Luo H
Front Oncol; 2022; 12():799475. PubMed ID: 35433487
[TBL] [Abstract][Full Text] [Related]
9.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
Front Genet; 2021; 12():692953. PubMed ID: 34490033
[No Abstract] [Full Text] [Related]
11. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma.
Xu D; Qin R; Li M; Shen J; Mao Y; Tang K; Zhang A; Wang D; Shi Y
Medicine (Baltimore); 2022 Nov; 101(46):e29683. PubMed ID: 36401386
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study.
Wu G; Deng Z; Jin Z; Wang J; Xu B; Zeng J; Peng M; Wen Z; Guo Y
Biomed Res Int; 2020; 2020():1346045. PubMed ID: 32596278
[TBL] [Abstract][Full Text] [Related]
14. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Shi X; Zhao Y; He R; Zhou M; Pan S; Yu S; Xie Y; Li X; Wang M; Guo X; Qin R
Oncotarget; 2018 May; 9(36):24248-24259. PubMed ID: 29849937
[TBL] [Abstract][Full Text] [Related]
15. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
Su K; Peng Y; Yu H
Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
[TBL] [Abstract][Full Text] [Related]
16. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma.
Luo Z; Wang L; Shang Z; Guo Q; Liu Q; Zhang M; Li T; Wang Y; Zhang Y; Zhang Y; Zhang X
Transl Oncol; 2022 Aug; 22():101462. PubMed ID: 35635957
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma.
Gong X; Liu Y; Zheng C; Tian P; Peng M; Pan Y; Li X
Front Oncol; 2022; 12():827259. PubMed ID: 35186758
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
Front Genet; 2021; 12():702102. PubMed ID: 34335699
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
20. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
Liang B; Zhao J; Wang X
PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
